CT Enterprise (03839) announced its annual performance, with a net profit attributable to shareholders of 11.168 million US dollars, an increase of 337.45% year-on-year.

CT Enterprise (03839) announced its annual results for the year ending on December 31, 2024. The group's revenue reached $308 million, an increase of 76.89% compared to the previous year. The profit attributable to shareholders of the company was $11.168 million, an increase of 337.45% compared to the previous year. Earnings per share were 4.41 cents. The announcement stated that the increase in profit was mainly due to the strong performance of the group's biochemical business. However, the profit attributable to the group's industrial business declined due to intense competition.